Navigation Links


Oxycodone in Medical News

Medicines Top Source of Kids' Poisonings

... most common reasons included relaxation, feeling good or getting high, experimentation and then pain relief. Students used drugs such as hydrocodone, oxycodone (Oxycontin), hydromorphone, meperidine, morphine and codeine without a prescription, the researchers found. The dangers of misused cold medications...

DURECT Corporation Announces Second Quarter 2009 Financial

...rking closely with the FDA toward approval of the product. REMOXY, an investigational drug, is a long acting oral formulation of oxycodone intended to treat moderate to severe pain. Based on DURECT's ORADUR(R) technology, which is covered by issued patents and pending patent...

Narconon Trois-Rivieres Cites 'Hillbilly Heroin' as Canadian Drug Addiction Crisis

... chronic illnesses and severe to mild pain relief. oxycodone is found in many different pain medications, but i... other chemicals. For example, Percocet has 5mg of oxycodone in it combined with acetaminophen, which is the co... drug found in Tylenol. In OxyContin there is only oxycodone in it, in its purest form. OxyContin tablets can c...

King Provides Additional Information on the REMOXY(R) NDA Resubmission Plan

...nues to anticipate the resubmission could occur mid-year 2010. About REMOXY (R) REMOXY(R), an investigational drug, is a unique, long-acting oxycodone formulation for moderate-to-severe chronic pain designed to reduce potential risks of unintended use. In mid-2008, an NDA for REMOXY(R) was accepted ...

REMOXY(R) NDA Update

...of the product. REMOXY, based on DURECT's ORADUR(TM) technology, is an investigational drug that is a unique, controlled release formulation of oxycodone for moderate-to-severe chronic pain designed to reduce potential risks of unintended use. In mid-2008, an NDA for REMOXY was accepted by the FDA and ...

If 2 Painkillers Are Banned, What Next?

...ately, can be used safely." Narcotic painkillers such as hydrocodone and oxycodone run the risk of being abused. "We want to get tighter control," Fishman sai...e pain relief from just one of the components in Percocet, he explained. oxycodone alone is "probably just as effective for pain," Shurman said. "Tylenol [ace...

NUCYNTA(TM) (tapentadol) CII Immediate Release Tablets Now Available for Relief of Moderate to Severe Acute Pain

...t efficacy in pain relief following orthopedic surgery and significant reduction in composite incidence of nausea and/or vomiting compared to 10-mg of oxycodone IR. IMPORTANT SAFETY INFORMATION Like other drugs with mu-opioid agonist activity, NUCYNTA(TM) is contraindicated in patients with signific...

KV Pharmaceutical Company, Purdue Pharma L.P. Settle OxyContin(R) Dispute

...eceives limited license rights to all strengths of oxycodone controlled-release tablets ST. LOUIS, June 9 ...with an abuse liability similar to morphine. oxycodone can be abused in a manner similar to other opioid ...blets are a controlled-release oral formulation of oxycodone hydrochloride indicated for the management of mode...

Pain Medicine Experts Recommend Monitoring, Education for All Opioid Medicines

...itimate pain." On May 27-28, 2009, the FDA will hold public hearings on its proposed REMS for extended release pain medications such as morphine, oxycodone and methadone. AAPM members have committed to working with the FDA to ensure that REMS for pain medicine takes the needs of the medical community and...

Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Roxicodone(R) Tablets

...es, Ltd. (NYSE Amex: CPD ) has recently launched oxycodone hydrochloride tablets on behalf of Sun Pharmaceuti...ion (ANDA) for generic Roxicodone(R) tablets. oxycodone hydrochloride tablets are an immediate-release oral formulation of oxycodone hydrochloride indicated for the management of mode...
Oxycodone in Medical Technology

New Study Suggests Tapentadol IR for Acute Pain Is Associated With Improved Gastrointestinal Tolerability Compared to Oxycodone IR

TAMPA, Fla., May 9 /PRNewswire-USNewswire/ -- Many strong acting pain medications have bothersome side effects. These can include nausea and vomiting with short-term use, and constipation with longer, chronic use. Such symptoms can lead patients to discontinue treatment, adding additional comp...

Phosphagenics to Conduct a Phase 1 Transdermal Oxycodone Clinical Trial

MELBOURNE, Australia, Sept. 17 /PRNewswire-FirstCall/ -- Phosphagenics Limited (ASX: POH, AIM: PSG, OTCQX: PPGNY) today announced that, following successful preclinical studies, it plans to undertake a Phase 1 transdermal oxycodone clinical trial aimed at providing chronic pain sufferers with ...

Acura and King Receive FDA Complete Response Letter Regarding Acurox(R)

...following submission of their response. About Acurox Tablets Acurox is a patented, orally administered, immediate release tablet containing oxycodone HCl as its sole active analgesic ingredient with a proposed indication for the relief of moderate-to-severe pain. Acurox utilizes Acura's proprietary...

King Pharmaceuticals Showcases Data From Pain Pipeline of Medicines Designed to Deter Common Methods of Non-Therapeutic Use

...) Tablets are a unique composition of short-acting oxycodone HCl, niacin and functional inactive ingredients in... with Aversion(R) Technology, are a composition of oxycodone HCl, niacin, and other inactive ingredients. The n...lerability of Niacin 30 mg and 60 mg Combined With oxycodone HCl 5 mg Versus...

New Phase 3 Study of Tapentadol Immediate Release Tablets Published in Current Medical Research and Opinion Journal

...nt reduction in nausea and/or vomiting compared to oxycodone IR. Results from the new Phase 3 study of t...d the same percentage of improvement with 10-mg of oxycodone IR. Results were similar for patients who experie...he tapentadol IR 75-mg group and 64 percent in the oxycodone IR 10-mg group. The most common treatment-eme...

QRxPharma Successfully Completes Comparative Study for Dual-Opioid(TM) Pain Therapy

... IR Provides Better Tolerability Than Morphine and oxycodone Alone SYDNEY, Australia and BEDMINSTER, N.J.,...cts. These results confirm 12mg/8mg morphine plus oxycodone combination as the preferred dose for optimal effi...ive patients greater tolerability than morphine or oxycodone alone," said Dr. John Holaday, Managing Director a...

Premier Research Announces Milestone New Drug Application

... our people," commented Dr. Troy McCall, Chief Operating Officer. Acurox(R), a patented, orally administered, immediate release tablet containing oxycodone HCl as its sole active analgesic ingredient, has a proposed indication for the relief of moderate to severe pain. Acurox(R) utilizes Acura Pharmaceut...

Advances in Science and Treatment of Pain Presented at 25th Annual American Academy of Pain Medicine Meeting January 28 - 31, 2009

...r 193 Tramadol Outcomes, Poster 197 Safety, Tolerability and Effectiveness of Duloxetine for Fibromyalgia, Poster 204 Effects of Oral oxycodone in Recreational Drug Users, Poster 211 Evaluation of High Dose Opioids in Chronic Pain Patients, Poster 220 Long Term Opioid Therapy May Suppr...

REMOXY(R) NDA Filing Accepted by FDA and Priority Review Granted

...rights for this drug candidate to King Pharmaceuticals (NYSE: KG ). REMOXY, an investigational drug, is a unique, abuse-resistant, controlled release oxycodone for moderate-to-severe chronic pain. About ORADUR(TM) Technology ORADUR is a proprietary technology designed to transform short-acting oral capsul...

QRxPharma Releases Additional Phase 3 Data for Q8003IR 'Dual Opioid' Pain Therapy

... John Holaday, Managing Director and Chief Executive Officer, QRxPharma. "These data confirm that our patented dual opioid combination of morphine and oxycodone provides synergistic effects on pain relief and is able to achieve equal or better analgesia at materially lower doses than the active opioid comparat...
Oxycodone in Biological News

A new target for painkillers

...are painful. Common pain medicines like aspirin, ibuprofen and acetaminophen often fail to relieve neuropathic pain. Morphine-like opiods such as oxycodone sometimes are used, but can cause constipation, nausea and a spaced-out feeling. Anticonvulsant drugs for epilepsy sometime are used to reduce t...
Oxycodone in Biological Technology

Phosphagenics Announces Successful Phase 1 Transdermal Oxycodone Clinical Trial Results

MELBOURNE, Australia, Dec. 17 /PRNewswire-FirstCall/ -- Phosphagenics Limited ("Phosphagenics") (ASX: POH, AIM: PSG, OTCQX: PPGNY) today announced positive results of its Phase 1 clinical trial that showed its delivery technology, TPM, delivered leading pain-relief drug oxycodone through the s...

New Phase III Data Demonstrate Oxycodone / Naloxone Combination Tablet Reduces Opioid-Induced Bowel Dysfunction in Patients With Chronic Severe Pain

New Approach in the Development of Opioid-Based Pain Management Therapy Improves Bowel Function CAMBRIDGE, England, September 26 /PRNewswire/ -- The oral prolonged-release (PR) oxycodone / naloxone combination tablet reduces opioid-induced bowel dysfunction in patients w...

IntelliPharmaCeutics Announces Successful Completion of a Pilot Clinical Trial for its Abuse and Alcohol Resistant Sustained Release Oxycodone

TORONTO, March 27 /PRNewswire/ - IntelliPharmaCeutics Ltd. (Delaware) is pleased to announce significant results from a recently completed pilot clinical trial for its new abuse-resistant, alcohol-resistant once-a-day oral oxycodone formulation by its operating company IntelliPharmaCeutics Cor...

QRxPharma Initiates Comparative Phase 2 Proof-of-Concept Study for MoxDuo(TM) IV Pain Therapy

...te that the Company's MoxDuo(TM) IR oral formulation consistently yields superior pain relief with a lower frequency of side effects than morphine and oxycodone alone. We believe our intravenous formulation will demonstrate similar benefits as seen with orally administered MoxDuo(TM) IR," said Dr. Holaday. "...

King and Pain Therapeutics Announce REMOXY(R) NDA Update

...o working closely with the FDA toward approval of the product. About REMOXY (R) REMOXY, an investigational drug, is a unique, long-acting oxycodone formulation for moderate-to-severe chronic pain designed to reduce potential risks of unintended use. In mid-2008, an NDA for REMOXY was accepted by ...

Phosphagenics Announces Completion of Transdermal Patch Prototypes

... - oxycodone Successfully Delivered into the Bloodstream -...es Sustained Release and Increased Blood Levels of oxycodone MELBOURNE, Australia, May 29 /PRNewswire-Firs...ystems developed by Phosphagenics, the delivery of oxycodone was significantly increased when compared to the C...

QRxPharma Initiates Second Comparative Study for MoxDuo(TM) IR Dual-Opioid(TM) Pain Therapy

... date, data indicate that QRxPharma's patented combination of morphine plus oxycodone works synergistically to increase analgesia while diminishing the usual sid... (bunionectomy) pain that compares MoxDuo(TM) IR against morphine alone and oxycodone alone, and a placebo-controlled study of the effectiveness of MoxDuo(TM) IR...

ETHEX Corporation Issues Nationwide Voluntary Recall of Products

...ating Tablets, 8mg (58177-364-22 & 364-56) oxycodone HCl Capsules, 5mg (58177-041-04 & 041-11) oxycodone HCl IR Tablets, 10mg (58177-461-04) oxycodone HCl IR Tablets, 15mg, (58177-445-04) ...

QRxPharma Initiates Comparative Study for MoxDuoIR(TM) Dual-Opioid(TM) Pain Therapy

...against equivalent analgesic doses of morphine and oxycodone alone for the treatment of acute moderate to sever...ared to equivalent analgesic doses of morphine and oxycodone alone," said Dr. John Holaday, Managing Director a...(TM) efficacy and safety to corresponding doses of oxycodone and morphine in patients experiencing moderate to ...

Purdue Pharma L.P. Announces Resolution of OxyContin(R) Patent Lawsuit with Mallinckrodt Inc.

...e licenses limited sales of some generic oxycodone strengths STAMFORD, Conn., Sept. 2 /PRNewswire/ ...of 10 mg, 20 mg, 40 mg, and 80 mg extended-release oxycodone tablets. In the most recent decision in the liti...nce with an abuse liability similar to morphine. oxycodone can be abused in a manner similar to other opioid ...
Oxycodone in Biological Definition

Drug

...r euphoric effects Opiates refined from the opium poppy Morphine Codeine Synthetic and semi-synthetic opioids Heroin oxycodone (sold under the brand name Oxycontin, and contained in Percocet ) Vicodin Demerol Darvocet Tramadol Fentanyl R...
Other TagsSiliconizedTrocar
(Date:12/15/2009)... decide benefits of imaging outweigh the risks , , TUESDAY, ... a serious risk to people with heart pacemakers, researchers ... pacemakers to a simulated MRI magnetic field and then ... the pacemaker lead, where it would touch the interior ... magnetic pulses caused certain pacemakers to deliver a drastically ...
(Date:12/15/2009)... is proud to announce the addition of David Tokofsky ... as Director of Development in the State of California ... ,, David Tokofsky was elected to the ... June 1995. As the Board Member for District Five, ... Northeast Los Angeles through East Los Angeles to the ...
(Date:12/15/2009)... 15 Mergers and acquisitions are commonplace ... reach globally or complete a product portfolio they ... of safety programs. ,, A new free, white ... in a Hearing Conservation Program: US Airways ," ... America West led the newly formed company to ...
(Date:12/15/2009)... Reportlinker.com announces that a ... in its catalogue: ,, ... - Market Forecasts to 2015, Competitive ... ,, http://www.reportlinker.com/p0168100/The-Future-of-Autoimmune-Diseases-Therapeutics---Market-Forecasts-to-2015-Competitive-Benchmarking-Product-Pipeline-and-Deals-Analysis.html ... author has released its latest research ...
(Date:12/15/2009)... shows a direct correlation between effective workplace health ... culture of health improvement can result in lower ... white paper from The Vitality Group, a provider ... ideal setting for the delivery of health and ... culture of health is a critical component in ...
Breaking Medicine News(10 mins):Health News:Patients With Pacemakers Should Avoid MRI Scans 2Health News:Accelify Announces the Addition of David Tokofsky to its National Board of Advisors 2Health News:New White Paper Details Best Practices of an Occupational Hearing Conservation Program: US Airways 2Health News:New White Paper Details Best Practices of an Occupational Hearing Conservation Program: US Airways 3Health News:New White Paper Details Best Practices of an Occupational Hearing Conservation Program: US Airways 4Health News:Reportlinker Adds The Future of Autoimmune Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 2Health News:Reportlinker Adds The Future of Autoimmune Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 3Health News:Reportlinker Adds The Future of Autoimmune Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 4Health News:Reportlinker Adds The Future of Autoimmune Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 5Health News:Reportlinker Adds The Future of Autoimmune Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 6Health News:Reportlinker Adds The Future of Autoimmune Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 7Health News:Reportlinker Adds The Future of Autoimmune Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 8Health News:Reportlinker Adds The Future of Autoimmune Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 9Health News:Reportlinker Adds The Future of Autoimmune Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 10Health News:Reportlinker Adds The Future of Autoimmune Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 11Health News:Reportlinker Adds The Future of Autoimmune Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 12Health News:Reportlinker Adds The Future of Autoimmune Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 13Health News:Reportlinker Adds The Future of Autoimmune Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 14Health News:Reportlinker Adds The Future of Autoimmune Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 15Health News:Reportlinker Adds The Future of Autoimmune Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 16Health News:Reportlinker Adds The Future of Autoimmune Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 17Health News:Reportlinker Adds The Future of Autoimmune Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 18Health News:Reportlinker Adds The Future of Autoimmune Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 19Health News:Reportlinker Adds The Future of Autoimmune Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 20Health News:Reportlinker Adds The Future of Autoimmune Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 21Health News:Reportlinker Adds The Future of Autoimmune Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 22Health News:Reportlinker Adds The Future of Autoimmune Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 23Health News:Optimizing Corporate Culture is Critical to the Success of Wellness Programs 2
(Date:12/14/2009)... (Dec. 14, 2009) -- Researchers at Rice University and ... nanoparticle that can be tracked in real time with ... them with a fluorescent dye and kills them with ... examples from a growing field called "theranostics" that develops ... in a single procedure. , The research is available ...
(Date:12/14/2009)... have founded a new journal Cardiovascular Engineering and ... is a forum for research on all aspects of ... of the new quarterly journal will appear in March ... Annals of Biomedical Engineering and Cellular ... Technology will present a wide spectrum of research, ...
(Date:12/14/2009)... feature of humans. That,s until examples of tool use came ... of other mammals. Now, a report in the December 14th ... adds an octopus to the growing list of tool users. ... that the researchers call stilt walking. In it, the soft-bodied ... its eight arms rigid, and raises the whole assembly to ...
Breaking Biology News(10 mins):Tracking new cancer-killing particles with MRI 2Biomedical Engineering Society's new journal to be published by Springer 2Tool use in an invertebrate: The coconut-carrying octopus 2Hard to Treat Diseases Inc 28HTDS 29 and Landstar Inc 28LDSR 29 Retain Auditors 56644 1Hard to Treat Diseases Inc 28HTDS 29 and Landstar Inc 28LDSR 29 Retain Auditors 56644 2Hard to Treat Diseases Inc 28HTDS 29 and Landstar Inc 28LDSR 29 Retain Auditors 56644 3Labopharm to present data on its novel trazodone formulation at three upcoming international medical meetings 56641 1Labopharm to present data on its novel trazodone formulation at three upcoming international medical meetings 56641 2Labopharm to present data on its novel trazodone formulation at three upcoming international medical meetings 56641 3Investors From 24 States Will Visit Madison for 09 MidAmerica Healthcare Venture Forum 56638 1Investors From 24 States Will Visit Madison for 09 MidAmerica Healthcare Venture Forum 56638 2Investors From 24 States Will Visit Madison for 09 MidAmerica Healthcare Venture Forum 56638 3
Other Contentsshouldershouldershouldershouldershouldershouldershuntshuntshuntsicksicksicksickanemiaanemiaanemiaanemiaanemiaanemiaanemiaanemiaanemiasicklesicklesicklesicklesicklesigmoidsigmoidsigmoidoscopysigmoidoscopysilicosis